JMP Securities Downgrades Uroplasty (UPI) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts UPI Hot Sheet
Price: $1.22 --0%
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 18
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 18
Join SI Premium – FREE
JMP Securities downgraded Uroplasty (NASDAQ: UPI) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Uroplasty click here. For more ratings news on Uroplasty click here.
Shares of Uroplasty closed at $4.22 yesterday.
For an analyst ratings summary and ratings history on Uroplasty click here. For more ratings news on Uroplasty click here.
Shares of Uroplasty closed at $4.22 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Downgrades Botanix Pharmaceuticals Ltd (BOT:AU) to Hold
- Keefe, Bruyette & Woods Downgrades Bank of Hawaii (BOH) to Market Perform, 'Risk/Reward More Balanced in the Current Backdrop'
- CIBC Downgrades Mercer International (MERC) to Underperformer
Create E-mail Alert Related Categories
DowngradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
